Table 2.
Mapping resistance extent (%) within the Staphylococcus isolates collected from patients.
| Type of Antibiotics | CoPS | CoNS | p Value | |||
|---|---|---|---|---|---|---|
| Code | No | % | No | % | % | |
| Vancomycin | 1 | 11 | 23.9 | 3 | 15.0 | χ2 = 0.663 p = 0.416 |
| Amoxicillin–clavulanate | 2 | 20 | 43.5 | 19 | 95.0 | χ2 = 15.31 p < 0.001 * |
| Erythromycin | 3 | 28 | 60.9 | 15 | 75.0 | χ2 = 1.23 p = 0.268 |
| Trimethoprim–sulfamethoxazole | 4 | 21 | 45.7 | 8 | 40.0 | χ2 = 0.181 p = 0.671 |
| Imipenem | 5 | 15 | 32.6 | 18 | 90.0 | χ2 = 0.181 p < 0.001 * |
| Oxacillin | 6 | 43 | 93.5 | 18 | 90.0 | χ2 = 0.241 p = 0.624 |
| Ceftriaxone | 7 | 28 | 60.9 | 19 | 95.0 | χ2 = 7.92 p = 0.005 * |
| Clindamycin | 8 | 35 | 76.1 | 10 | 50.0 | χ2 = 4.37 p = 0.037 * |
* Statistically significant (at p < 0.05) using Chi-square test.